AllSight
Companies · STTK · Pharmaceutical Preparations

Shattuck Labs, Inc. (STTK)

Shattuck Labs, Inc. (STTK) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Shattuck Labs, Inc. (STTK) stock — financials & valuation

Key numbers for Shattuck Labs, Inc. (STTK): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 40/100 — a percentile rank of Shattuck Labs, Inc.’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.

Market cap$686.5M
P / S686.5×
EV / EBITDA-11.9×
Gross margin100.0%
Operating margin-5578.7%
Net margin-5256.8%
Return on equity-24.9%
ROIC-37.7%
Revenue growth-66.6%
Debt / equity0.0×
Dividend yield0.0%

Is Shattuck Labs, Inc. overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from Shattuck Labs, Inc.’s own financial statements and shown as context, never as advice.

Aug 11, 2026
Phase 1 clears key safety hurdles; Phase 2 launch remains on track
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact